201 related articles for article (PubMed ID: 35314321)
1. Immune responses in the Parkinson's disease brain.
Weiss F; Labrador-Garrido A; Dzamko N; Halliday G
Neurobiol Dis; 2022 Jun; 168():105700. PubMed ID: 35314321
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation and protein pathology in Parkinson's disease dementia.
Kouli A; Camacho M; Allinson K; Williams-Gray CH
Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
[TBL] [Abstract][Full Text] [Related]
3. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
Galiano-Landeira J; Torra A; Vila M; Bové J
Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
[TBL] [Abstract][Full Text] [Related]
4. Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease.
Bartl M; Xylaki M; Bähr M; Weber S; Trenkwalder C; Mollenhauer B
Neurobiol Dis; 2022 Aug; 170():105744. PubMed ID: 35513230
[TBL] [Abstract][Full Text] [Related]
5. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
[TBL] [Abstract][Full Text] [Related]
6. The major histocompatibility complex participates in Parkinson's disease.
Gu R; Pan J; Awan MUN; Sun X; Yan F; Bai L; Bai J
Pharmacol Res; 2024 May; 203():107168. PubMed ID: 38583689
[TBL] [Abstract][Full Text] [Related]
7. Microglia and astrocyte activation is region-dependent in the α-synuclein mouse model of Parkinson's disease.
Basurco L; Abellanas MA; Ayerra L; Conde E; Vinueza-Gavilanes R; Luquin E; Vales A; Vilas A; Martin-Uriz PS; Tamayo I; Alonso MM; Hernaez M; Gonzalez-Aseguinolaza G; Clavero P; Mengual E; Arrasate M; Hervás-Stubbs S; Aymerich MS
Glia; 2023 Mar; 71(3):571-587. PubMed ID: 36353934
[TBL] [Abstract][Full Text] [Related]
8. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
9. Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.
Gu XL; Long CX; Sun L; Xie C; Lin X; Cai H
Mol Brain; 2010 Apr; 3():12. PubMed ID: 20409326
[TBL] [Abstract][Full Text] [Related]
10. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain.
Rostami J; Fotaki G; Sirois J; Mzezewa R; Bergström J; Essand M; Healy L; Erlandsson A
J Neuroinflammation; 2020 Apr; 17(1):119. PubMed ID: 32299492
[TBL] [Abstract][Full Text] [Related]
11. Microglia and astrocyte dysfunction in parkinson's disease.
Kam TI; Hinkle JT; Dawson TM; Dawson VL
Neurobiol Dis; 2020 Oct; 144():105028. PubMed ID: 32736085
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
13. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
Zheng T; Zhang Z
Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990
[TBL] [Abstract][Full Text] [Related]
14. Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration.
Peralta Ramos JM; Iribarren P; Bousset L; Melki R; Baekelandt V; Van der Perren A
Front Immunol; 2019; 10():80. PubMed ID: 30761145
[TBL] [Abstract][Full Text] [Related]
15. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.
Vargas JY; Grudina C; Zurzolo C
Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184
[TBL] [Abstract][Full Text] [Related]
16. Microglia in Parkinson's Disease.
Stefanova N
J Parkinsons Dis; 2022; 12(s1):S105-S112. PubMed ID: 35754289
[TBL] [Abstract][Full Text] [Related]
17. Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice.
Karikari AA; McFleder RL; Ribechini E; Blum R; Bruttel V; Knorr S; Gehmeyr M; Volkmann J; Brotchie JM; Ahsan F; Haack B; Monoranu CM; Keber U; Yeghiazaryan R; Pagenstecher A; Heckel T; Bischler T; Wischhusen J; Koprich JB; Lutz MB; Ip CW
Brain Behav Immun; 2022 Mar; 101():194-210. PubMed ID: 35032575
[TBL] [Abstract][Full Text] [Related]
18. Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.
Lee Y; Lee S; Chang SC; Lee J
Arch Pharm Res; 2019 May; 42(5):416-425. PubMed ID: 30830660
[TBL] [Abstract][Full Text] [Related]
19. Impact of sex on neuroimmune contributions to Parkinson's disease.
Bourque M; Morissette M; Soulet D; Di Paolo T
Brain Res Bull; 2023 Jul; 199():110668. PubMed ID: 37196734
[TBL] [Abstract][Full Text] [Related]
20. Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.
Sanchez-Guajardo V; Febbraro F; Kirik D; Romero-Ramos M
PLoS One; 2010 Jan; 5(1):e8784. PubMed ID: 20098715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
